ISPOR - POSA225 Comparing the US Drug Development, Pricing, Access, and Reimbursement Strategies for COVID-19 Vaccines as a Potential Model for Novel Oncology Therapies

POSA225 Comparing the US Drug Development, Pricing, Access, and Reimbursement Strategies for COVID-19 Vaccines as a Potential Model for Novel Oncology Therapies

Abstract

Authors

Y Lee K Lee H Park M Neese ZM Khan

Full Text Cite This Article

Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now